... january
6, 2005
The
new england journal
of
medicine
29
original article
Statin Therapy, LDL Cholesterol,
C-Reactive Protein, and Coronary Artery Disease
Steven E. Nissen, M.D., ... Massachusetts Medical Society. All rights reserved.
Statin Therapy, LDL
Cholesterol, C-Reactive
Protein, and Coronary
Artery Disease
n engl j m...
... [3,4].
Patients with coronary artery disease (CAD) and refrac-
tory or recurrent retrosternal symptoms have a reduction
in life expectancy and HRQL compared to patients w ith
stable coronary artery disease ... Gastroenterology, Vascular Diseases and Internal
Medicine, Nicolaus Copernicus University in Toruń, Ludwik Rydygier
Collegium Medicum, Bydgoszcz, Poland.
2
Clinical Wa...
... CHD and coronary- artery calcium scores.
Past or current smoking and the presence of hy-
pertension, a high cholesterol level, and diabetes
were all strongly predictive of elevated coronary-
artery ... estrogens and
coronary- artery calcium scores and would not ex-
plain our findings.
Although WHI-CACS did not include all par-
ticipants who had undergone randomization in...
... patients with coronary artery disease and
preserved ejection fraction who receive intensive
current standard therapy, usually including coronary
revascularization and lipid-lowering agents, and in
whom ...
15
and EUROPA
the European Trial on Reduction of Cardiac Events with Perindopril in Stable Coronary Artery Disease.
16
† The analysis included 3432 patients...
... AJ.
Effects of PPARα, γ and δ haplotypes on plasma levels of lipids
and progression of coronary atherosclerosis and response to statin
therapy in the lipoprotein coronary atherosclerosis study. ... VLDL
and LDL levels were observed. Results in support of our
findings were also obtained by Chen et al. [11], who
studied 4 PPARδ haplotypes and found that effects on
plasma...
... 1
Pathogenesis
Coronary Artery Disease – New Insights and Novel Approaches
28
3.6 Gene-gene and gene-environmental interaction in manifestation of coronary artery
disease
The fact that ... influencing various aspects of coronary artery function and structure with prevalent
genetic factors.
Coronary Artery Disease – New Insights and Novel Approaches
2...
... Epidemiology and Pathophysiology
of Coronary Artery Disease 1
Chapter 1 Epidemiology of Coronary Artery Disease 3
John F. Beltrame, Rachel Dreyer and Rosanna Tavella
Chapter 2 Gender Differences in Coronary ... 4 Coronary Microvascular Dysfunction in CAD:
Consequences and Potential Therapeutic Applications 65
Alan N. Beneze, Jeffrey M. Gold and Betsy B. Dokken
C...
... adhesion, flow cytometry and serum TXB
2
levels for
monitoring platelet inhibiting treatment with ASA and clopidogrel
in coronary artery disease: a randomised cross-over study
Andreas C Eriksson*
1
, ... patients with coronary artery
disease and controls
The factors were further analysed by One-sample t-test for
differences between patients and controls. Thus, platelet
a...